Characterization of Twitter-based dialogue related to renal cell carcinoma (RCC)
Characterization of Twitter-based dialogue related to renal cell carcinoma (RCC) Abstract Social...
Read More
Kidney Cancer Journal
Axitinib and Cabozantinib in the treatment of sunitinib-refractory patients with metastatic renal cell carcinoma (mRCC): Results of matching adjusted indirect treatment comparison (MAIC) analysis of AXIS and METEOR trials
Axitinib and Cabozantinib in the treatment of sunitinib-refractory patients with metastatic renal...
Read More
Association between stool bacteriomic profile and response to sunitinib in metastatic renal cell carcinoma (mRCC)
Association between stool bacteriomic profile and response to sunitinib in metastatic renal cell...
Read More
Association between pretreatment neutrophil-to-lymphocyte ratio and outcome of patients with metastatic renal cell carcinoma treated with nivolumab
Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and...
Read More
Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and therapy management in S-TRAC trial
Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and...
Read MoreExercise & Wellness
Mark A. Moyad, MD, MPH
University of Michigan
Ann Arbor, Michigan